Nucleophilic covalent ligand discovery for the cysteine redoxome

被引:13
|
作者
Fu, Ling [1 ]
Jung, Youngeun [2 ]
Tian, Caiping [1 ,3 ]
Ferreira, Renan B. [2 ]
Cheng, Ruifeng [1 ,4 ]
He, Fuchu [1 ,3 ]
Yang, Jing [1 ]
Carroll, Kate S. [2 ]
机构
[1] Beijing Inst Life, Beijing Proteome Res Ctr, Natl Ctr Prot Sci Beijing, State Key Lab Prote, Beijing, Peoples R China
[2] UF Scripps Biomed Res, Dept Chem, Jupiter, FL 33458 USA
[3] Tsinghua Univ, Sch Med, Beijing, Peoples R China
[4] Anhui Med Univ, Sch Basic Med Sci, Hefei, Peoples R China
基金
国家重点研发计划; 美国国家卫生研究院;
关键词
PROTEIN; CHEMISTRY; PROBES; TOOLS;
D O I
10.1038/s41589-023-01330-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With an eye toward expanding chemistries used for covalent ligand discovery, we elaborated an umpolung strategy that exploits the 'polarity reversal' of sulfur when cysteine is oxidized to sulfenic acid, a widespread post-translational modification, for selective bioconjugation with C-nucleophiles. Here we present a global map of a human sulfenome that is susceptible to covalent modification by members of a nucleophilic fragment library. More than 500 liganded sulfenic acids were identified on proteins across diverse functional classes, and, of these, more than 80% were not targeted by electrophilic fragment analogs. We further show that members of our nucleophilic fragment library can impair functional protein-protein interactions involved in nuclear oncoprotein transport and DNA damage repair. Our findings reveal a vast expanse of ligandable sulfenic acids in the human proteome and highlight the utility of nucleophilic small molecules in the fragment-based covalent ligand discovery pipeline, presaging further opportunities using non-traditional chemistries for targeting proteins.
引用
收藏
页码:1309 / +
页数:32
相关论文
共 50 条
  • [21] Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors
    Keeley, A.
    Abranyi-Balogh, P.
    Keseru, G. M.
    MEDCHEMCOMM, 2019, 10 (02) : 263 - 267
  • [22] Fragment-Based Discovery of Irreversible Covalent Inhibitors of Cysteine Proteases Using Chlorofluoroacetamide Library
    Miura, Chizuru
    Shindo, Naoya
    Okamoto, Kei
    Kuwata, Keiko
    Ojida, Akio
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (11) : 1074 - 1081
  • [23] Fragment-based covalent ligand discovery (vol 2, pg 354, 2021)
    Lu, Wenchao
    Kostic, Milka
    Zhang, Tinghu
    Che, Jianwei
    Patricelli, Matthew P.
    Jones, Lyn H.
    Chouchani, Edward T.
    Gray, Nathanael S.
    RSC CHEMICAL BIOLOGY, 2021, 2 (02): : 670 - 671
  • [24] Chemoproteomic Covalent Ligand Discovery as the PROTAC-gonist: The Future of Targeted Degradation Medicines
    Shishikura, Kyosuke
    Matthews, Megan L.
    ACS CENTRAL SCIENCE, 2024, 10 (07) : 1314 - 1317
  • [25] Lysine-Targeted Reversible Covalent Ligand Discovery for Proteins via Phage Display
    Zheng, Mengmeng
    Chen, Fa-Jie
    Li, Kaicheng
    Reja, Rahi M.
    Haeffner, Fredrik
    Gao, Jianmin
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (34) : 15885 - 15893
  • [26] High-Throughput Kinetic Analysis for Target-Directed Covalent Ligand Discovery
    Craven, Gregory B.
    Affron, Dominic P.
    Allen, Charlotte E.
    Matthies, Stefan
    Greener, Joe G.
    Morgan, Rhodri M. L.
    Tate, Edward W.
    Armstrong, Alan
    Mann, David J.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2018, 57 (19) : 5257 - 5261
  • [27] Covalent tethering of fragments for covalent probe discovery
    Kathman, Stefan G.
    Statsyuk, Alexander V.
    MEDCHEMCOMM, 2016, 7 (04) : 576 - 585
  • [28] NUCLEOPHILIC LIGAND EXCHANGE BY PHOSPHORANES
    SCHLOSSER, M
    KADIBELB.T
    STEINHOF.G
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1966, 5 (11) : 968 - +
  • [29] Discovery of Covalent MLKL PROTAC Degraders via Optimization of a Theophylline Derivative Ligand for Treating Necroptosis
    Li, Shang
    Ma, Liangliang
    Li, Xinxin
    Jiang, Yuhan
    Luo, Zhongwen
    Yin, Fucheng
    Zhang, Yonglei
    Chen, Yifan
    Wan, Siyuan
    Zhou, Han
    Kong, Lingyi
    Wang, Xiaobing
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (17) : 15353 - 15372
  • [30] Discovery of a non-covalent ligand for Rpn-13, a therapeutic target for hematological cancers
    Loy, Cody A.
    Muli, Christine S.
    Ali, Eslam M. H.
    Xie, Dan
    Ahmed, Mostafa H.
    Post, Carol Beth
    Trader, Darci J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 95